• Keros Therapeutics, Inc. (NASDAQ:KROS) Given Average Recommendation of "Moderate Buy" by Brokerages

    المصدر: Buzz FX / 12 يناير 2025 03:40:17   America/Chicago


    Keros Therapeutics, Inc. (NASDAQ:KROS) Given Average Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat January 12, 2025 Share Link copied to clipboard. Keros Therapeutics, Inc. ( NASDAQ:KROS - Get Free Report ) has been g
    Read more...
شارك على،